Kilby K, Mathias H, Boisvenue L et al. Micronutrient Absorption and Related Outcomes in People with Inflammatory Bowel Disease: A Review. Nutrients.2019;11.

Lim GE, Huang GJ, Flora N, et al. Insulin regulates Glucagon-Like Peptide-1 secretion from the enteroendocrine L cell. Endocrinology. 2009;150:580–91.

CAS  PubMed  PubMed Central  Google Scholar 

Lee Y-S, Jun H-S. Anti-Inflammatory effects of GLP-1-Based therapies beyond glucose control. Mediators Inflamm.2016;2016.

Kissow H, Hartmann B, Holst JJ, et al. Glucagon-like peptide-1 as a treatment for chemotherapy-induced mucositis. Gut. 2013;62:1724–33.

CAS  PubMed  Google Scholar 

Yusta B, Baggio LL, Koehler J, et al. GLP-1R agonists modulate enteric immune responses through the intestinal intraepithelial lymphocyte GLP-1R. Diabetes. 2015;64:2537–49.

CAS  PubMed  Google Scholar 

Bang-Berthelsen CH, Holm TL, Pyke C, et al. GLP-1 induces barrier protective expression in Brunner’s glands and regulates colonic inflammation. Inflamm Bowel Dis. 2016;22:2078–97.

PubMed  Google Scholar 

Antwi K, Fani M, Nicolas G, et al. Localization of hidden insulinomas with ⁶⁸Ga-DOTA-Exendin-4 PET/CT: A pilot study. J Nucl Med. 2015;56:1075–8.

CAS  PubMed  Google Scholar 

Fujimoto H, Fujita N, Hamamatsu K, et al. First-in-Human evaluation of positron emission tomography/computed tomography with [(18)F]FB(ePEG12)12-Exendin-4: A phase 1 clinical study targeting GLP-1 receptor expression cells in pancreas. Front Endocrinol (Lausanne). 2021;12:717101.

PubMed  Google Scholar 

Pan Y, Lv J, Pan D, et al. Evaluating the utility of human glucagon-like peptide 1 receptor gene as a novel radionuclide reporter gene: a promising molecular imaging tool. Appl Microbiol Biotechnol. 2019;103:1311–24.

CAS  PubMed  Google Scholar 

Murano M, Maemura K, Hirata I, et al. Therapeutic effect of intracolonically administered nuclear factor ΚB (p65) antisense oligonucleotide on mouse dextran sulphate sodium (DSS)-induced colitis. Clin Exp Immunol. 2000;120:51–8.

CAS  PubMed  PubMed Central  Google Scholar 

Adler J, Punglia DR, Dillman JR, et al. Computed tomography enterography findings correlate with tissue inflammation, not fibrosis in resected small bowel Crohn’s disease. Inflamm Bowel Dis. 2012;18:849–56.

PubMed  Google Scholar 

Bettenworth D, Reuter S, Hermann S, et al. Translational 18F-FDG PET/CT imaging to monitor lesion activity in intestinal inflammation. J Nucl Med. 2013;54:748–55.

CAS  PubMed  Google Scholar 

Luo Y, Yu M, Pan Q, et al. 68Ga-NOTA-exendin-4 PET/CT in detection of occult Insulinoma and evaluation of physiological uptake. Eur J Nucl Med Mol Imaging. 2015;42:531–2.

Zhang P, Zhao Z, Zhang L, et al. 68Ga-NOTA-MAL-Cys39-exendin-4, a potential GLP-1R targeted PET tracer for the detection of Insulinoma. Nucl Med Biol. 2019;74–75:19–24.

PubMed  Google Scholar 

Pyke C, Heller RS, Kirk RK, et al. GLP-1 receptor localization in monkey and human tissue: novel distribution revealed with extensively validated monoclonal antibody. Endocrinology. 2014;155:1280–90.

Andersen DB, Grunddal KV, Pedersen J et al. Using a Reporter Mouse to Map Known and Novel Sites of GLP-1 Receptor Expression in Peripheral Tissues of Male Mice. Endocrinology.2021;162.

Manell E, Puuvuori E, Svensson A et al. Exploring the GLP-1-GLP-1R axis in Porcine pancreas and Gastrointestinal tract in vivo by ex vivo autoradiography. BMJ Open Diabetes Res Care.2021;9.

Grunddal KV, Jensen EP, Orskov C et al. Expression Profile of the GLP-1 Receptor in the Gastrointestinal Tract and Pancreas in Adult Female Mice. Endocrinology.2022;163.

Anand U, Yiangou Y, Akbar A et al. Glucagon-like peptide 1 receptor (GLP-1R) expression by nerve fibres in inflammatory bowel disease and functional effects in cultured neurons. PLoS ONE.2018;13.

Zatorski H, Salaga M, Zielinska M, et al. Colonic inflammation induces changes in glucose levels through modulation of incretin system. Pharmacol Rep. 2021;73:1670–9.

CAS  PubMed  PubMed Central  Google Scholar 

Holst JJ, Andersen DB, Grunddal KV. Actions of glucagon-like peptide-1 receptor ligands in the gut. Br J Pharmacol. 2022;179:727–42.

CAS  PubMed  Google Scholar 

Wong CK, Yusta B, Koehler JA, et al. Divergent roles for the gut intraepithelial lymphocyte GLP-1R in control of metabolism, microbiota, and T cell-induced inflammation. Cell Metab. 2022;34:1514–31.

CAS  PubMed  Google Scholar 

Neurath MF. Cytokines in inflammatory bowel disease. Nat Rev Immunol. 2014;14:329–42.

CAS  PubMed  Google Scholar 

Hong D, Kim HK, Yang W et al. Integrative analysis of single-cell RNA-seq and gut Microbiome metabarcoding data elucidates macrophage dysfunction in mice with DSS-induced ulcerative colitis. Commun Biol.2024;7.

Marso SP, Daniels GH, Brown-Frandsen K, et al. Liraglutide and cardiovascular outcomes in type 2 diabetes. N Engl J Med. 2016;375:311–22.

CAS  PubMed  PubMed Central  Google Scholar 

Villumsen M, Schelde AB, Jimenez-Solem E et al. GLP-1 based therapies and disease course of inflammatory bowel disease. EClinicalMedicine.2021;37.